ArticleInternational journal of clinical oncology2024

Comparative analysis of dual immune checkpoint inhibitor combination therapy versus immune checkpoint inhibitor plus tyrosine kinase inhibitor combination therapy for renal cell carcinoma with inferior vena cava tumor thrombosis.

Kazuhiko Yoshida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.